Lv4
550 积分 2025-02-05 加入
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6
5天前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
20天前
已完结
In Vivo CAR T-Cell Therapy Spurs 100% ORR in Phase I
22天前
已关闭
Non-gene-edited, CD19-targeted, allogeneic CAR-T cell therapy for relapsed or refractory B-cell acute lymphoblastic leukemia: an open-label, single-arm phase 1 study
28天前
已完结
Dual CAR-T cell therapy targeting CD19 and BCMA as a novel opportunity for immune reset in systemic lupus erythematosus
1个月前
已完结
Rapid receptor internalization potentiates CD7-targeted lipid nanoparticles for efficient mRNA delivery to T cells and in vivo CAR T-cell engineering
1个月前
已完结
Resetting autoimmune disease with CAR cell therapies
1个月前
已完结
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
1个月前
已完结
In vivo CAR T purchase spree continues with Lilly deal worth up to US$7 billion
1个月前
已关闭
Sovleplenib in patients with primary or secondary warm autoimmune haemolytic anaemia: results from phase 2 of a randomised, double-blind, placebo-controlled, phase 2/3 study
2个月前
已完结
皖公网安备34019202002308
